logo
Share SHARE
FONT-SIZE Plus   Neg

Triumph Group Q4 Profit Rises - Quick Facts

Triumph Group Inc. (TGI) Wednesday reported an increase in profit for the fourth quarter, due mainly to higher revenues.

The Berwyn, Pennsylvania-based company reported fourth-quarter net profit of $106.25 million or $2.03 per share, compared to $52.34 million or $1.02 per share last year.

For the quarter, income from continuing operations rose to $106.25 million or $2.03 per share from $54.03 million or $1.05 per share in the similar quarter last year.

Excluding acquisition and integration costs and curtailment gain, income from continuing operations increased to $81.90 million or $1.57 per share from $54.82 million or $1.07 per share in the similar quarter last year. On average, eight analysts polled by Thomson Reuters expected the company to earn $1.31 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter grew 3 percent to $946.38 million from $919.09 million in the prior-year quarter. Eleven analysts had a consensus revenue estimate of $919.64 million for the quarter.

Looking ahead, the company's Chairman and Chief Executive Richard Ill said, "We are entering our new fiscal year with a very strong backlog and a very solid balance sheet. We project sales in the range of $3.5 billion to $3.7 billion and earnings per share from continuing operations for the fiscal year of $5.45 to $5.55 per diluted share, excluding integration costs."

Analysts currently expect earnings of $4.77 per share for the year, with revenues of $3.38 billion.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT